top of page
Search Results

450 items found for "GPCR Drug Discovery"

  • About Us | Dr. GPCR Ecosystem

    GPCR Ecosystem We bring the GPCR community to fuel GPCR drug discovery one receptor at a time. The goal is to increase understanding of GPCR function and discover better drugs together. About Us: About Us Founded in 2020, we decided to bring together the GPCR community and break down any The goal is to better understand and exploit the druggability of GPCRs, together. To join the community you must be related to the GPCR field. Once in the Dr.

  • Ep 00 with Dr. Yamina Berchiche

    GPCR Podcast << Back to podcast list Dr. GPCR podcast , your host and founder, Dr. Yamina Berchiche introduces the very first podcast dedicated to GPCRs researcher and their work. GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well , grow, and thrive together to accelerate GPCR drug discovery and improve human health.

  • Ep 99 with Yamina Berchihce

    GPCR Podcast << Back to podcast list Dr. Yamina Berchiche About Dr. Yamina Berchiche Dr. Yamina A. GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR podcast. Dr.

  • Ep 98 with Dr. GPCR Team

    As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and adhesion GPCRs. (GPCRs), that control virtually everything in the body, as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR podcast. Dr.

  • Ep 81 with Dr. Christel Menet

    GPCR Podcast << Back to podcast list Dr. Christel Menet About Dr. was the 6th employee and today we are more than 60 :) I have fun every day, and I love working with GPCRs Christel Menet on the web Hyphen Projects GPCRS Drug Discovery Confo Therapeutics LinkedIn Dr. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

  • Ep 150 with Dr GPCR Team

    (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery discovery program.

  • Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    function The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Stephanie Häfner and Pharmacology-Enabling Drug Discovery Laurent Sabbagh Characterizing hADGRE5/CD97 Activation and Discovery for Human Adhesion GPCRs Stephanie Häfner Abstract "G Protein-coupled receptors (GPCRs) are drug discovery methods. bowel disease and small molecules drug discovery for polycystic kidney disease.

  • Dr. GPCR Summit 2021 Live Talks

    Streicher September 13, 2021 at 9:00:00 PM Learn More >> Through the Looking-Glass: Structure-Based Drug Discovery across the GPCRome Dr. Antibody Discovery and Optimization Dr. Sato September 14, 2021 at 7:00:00 PM Learn More >> Advancing GPCR drug discovery with bioSensAll® platform Demet Araç September 17, 2021 at 6:00:00 PM Learn More >> Structure-guided drug discovery Dr.

  • Ep 151 with Dr GPCR Board

    (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the biology and for the identification of drug targets and future drug development. She has made numerous important discoveries related to the mechanisms that control PAR1 signaling and discovery and genomic analysis, delivered technical presentations and software demonstrations to prospective

  • Session IX / Technology capsule: Light on aGPCR signaling and function | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program - A new platform for GPCR antibody drug discovery Abstract Developing monoclonal antibody drugs against GPCRs and other multi-pass transmembrane targets, such as ion channels, remains a significant challenge technology, demonstrated in the success of COVID-19 vaccines, is emerging as a promising method for antibody discovery developing highly specific antibodies for complex targets, with implications for overcoming challenges like drug

  • Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    signaling and function NovoiSMART - A new platform for GPCR antibody drug discovery Gavin Zhang Read Signaling and Pharmacology-Enabling Drug Discovery Fabian Pohl Structural Determinants Of GAIN Domain Stephanie Häfner The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Anne Bormann Placantonakis Antibody-drug conjugates targeting CD97 in glioblastoma Gabriela Aust Critical role for map of thermogenic fat Gavin Zhang NovoiSMART - A new platform for GPCR antibody drug discovery

  • C-Principles2 (List) | Dr. GPCR Ecosystem

    Principles of Pharmacology in Drug Discovery II Advanced Methods for the Optimization of Candidate Selection be exploited for new drug discovery. The five-lecture series describes essential additional elements to GPCR discovery programs that extend November 21st: Unconventional GPCR Ligands as Drugs. Pharmacology in Drug Discovery and Development (3rd ed.)

  • C-Principles1 (List) | Dr. GPCR Ecosystem

    Principles of Pharmacology in Drug Discovery I Techniques for Effective Lead Optimization of Candidate pharmacologic techniques and knowledge required to create a GPCR Target Program aimed at the discovery of new Drugs. The required elements of a comprehensive and effective GPCR Discovery. Modules: October 3rd: GPCR Project Initiation and Design for Discovery of New Molecules.

  • Advanced data analysis for GPCR pharmacology

    Advanced data analysis for GPCR pharmacology Dr. how to perform advanced GPCR pharmacology data analysis in support of drug discovery and GPCR research data analysis to a high level, as well as expertise that can be applied in drug discovery and target discovery and target research. discovery campaigns.

  • GPCR Courses

    informed in the world of GPCR. Terry Kenakin Principles of Pharmacology in Drug Discovery I Techniques for Effective Lead Optimization Terry Kenakin Principles of Pharmacology in Drug Discovery II Advanced Methods for the Optimization of Terry Kenakin Applying Pharmacology to Drug Discovery Watch Dr. Private groups 30+ Symposia recorded talks GPCR Job listings GPCR Event listings Direct access to members

  • University | Dr. GPCR Ecosystem

    GPCR University The Dr. staying informed in the world of GPCR. GPCR Courses Details Dr. GPCR Symposia Details Dr. GPCR Summit Details Dr. drug discovery. GPCR Strategic Partner

  • Illuminating Functional Selectivity and Allosterism at GPCRs.

    receptors involved in many, if not all, physiological responses, with the ultimate goal of improving drug in-cellulo measurement of protein-protein interactions, receptor trafficking and signalling, useful for drug discovery programs. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

  • Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer

    < GPCR News < GPCRs in Oncology and Immunology Small-molecule targeting of GPCR-independent noncanonical ) is a quintessential mechanism of cell signaling widely targeted by clinically approved drugs. Tags G protein , GPCR , cancer , drug discovery . papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology

  • The landscape of cancer-rewired GPCR signaling axes

    , and chemokine receptors, are the targets of multiple drugs displaying anti-growth effects in large-scale , cancer cell drug screens, which we further validated. , cancer , cancer cell lines , cell-cell communication , drug repurposing , personalized medicine , papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology

  • Plenary Lecture | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program Our first main research aspect is the identification of endogenous ligand of GPCRs. Our third main research aspect is working mechanism of GPCR. Our fourth main research aspect is ligand coding mechanisms and structural aided drug discovery of GPCR (Cell 2021, 2023, Nature 2023b), bile acids or its derivatives by GPCRs (Nature 2020)."

  • Classified News | Dr. GPCR Ecosystem

    GPCR Monthly Newsletter Weekly GPCR News about the GPCR field Sign Up Latest Classified GPCR News Adhesion dive into GPCR-ligand interactions Read More April 16, 2024 From DNA day to GPCR genomics Read More 66+ project Read More October 1, 2022 GPCRs: Signal Transduction Read More GPCR Binders, Drugs, and the Receptor-Associated G Proteins in Two Lepidopteran Species Read More October 1, 2024 Target-based discovery GPCR Strategic Partner

  • Session VII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program signaling pathway of the ADGRA homolog Remoulade in Drosophila Beatriz Blanco Redondo The Adhesion GPCR The mammalian Remo homolog ADGRA2/Gpr124 cooperates with other GPCRs of the Frizzled family, and the Anaesthesiology and Intensive Care, Medical Faculty, Leipzig University, Leipzig, Germany 5 Institute for Drug Discovery, Faculty of Medicine, Leipzig University 6 School of Medicine, University of Global Health

  • Ep 118 with Dr. David Sykes

    GPCR Podcast << Back to podcast list Dr. David Sykes About Dr. Discovery. David has over 20+ years of experience working in a drug discovery environment mainly in a specialist Discovery that he was awarded in 2020. discovery. " Dr.

  • Ep 19 with Dr. Fiona Marshall

    GPCR Podcast << Back to podcast list Dr. As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery stabilization and structure-based drug design. Marshall is the VP Head of Neuroscience Discovery and Head of Discovery UK, Global Head of Neuroscience discovery research leading teams in West Point, Boston, and London at MSD.

  • Ep 34 with Dr. Brian Arey

    GPCR Podcast << Back to podcast list Dr. Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular He continues to pioneer in drug discovery studying GPCRs and other target classes. I sat down with Brian to chat about GPCRs, working in the industry, and being a leader.

  • Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program GPCR Community Presentation Breaking Barriers: My Journey from Mexico to the Heart of the Dr. GPCR Ecosystem and beyond About Monserrat Avila Zozaya "My doctoral research was focused on investigating My research focuses on understanding the molecular mechanisms of adhesion GPCRs (aGPCRs) in lymphatic GPCR < Previous Session Next Session >

  • Ep 146 with Dr Michael Feigin

    target discovery. GPCR Targeted Drugs and Gene Regulation in Cancer Cells Mike presented research on the effect of GPCR-targeted lab, which led to the discovery of potential tumor suppressors and oncogenes in melanoma. Scientific Journey and Drug Discovery Challenges Mike shared significant moments in his scientific journey , including the discovery of RGS proteins and its impact on his research approach.

  • GprC of the nematode-trapping fungus Arthrobotrys flagrans activates mitochondria and reprograms fungal cells for nematode hunting

    < GPCR News < GPCRs in Oncology and Immunology GprC of the nematode-trapping fungus Arthrobotrys flagrans News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

bottom of page